Evidence map›Paper›PMID 32069067›Full record

Trial reportDiabetes technology & therapeutics2020

Efficacy of

Fernando Gomez-Peralta, Cristina Abreu, Sara Gomez-Rodriguez, Margarita Cruz-Bravo, Cristina María-Sanchez, Gema Poza, Luis Ruiz-Valdepeñas

Registry-linked trialAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Diabetes technology & therapeutics, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04847778 (Randomized Clinical Trial to Assess the Efficacy of the System Insulclock® 360 for Insulin Treatment Management in Type 1 Diabetes Patients With Insufficient Glycemic Control), which is not on this map. Cited by 14 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04847778 nacompletednot on this mapstarted 2021, after this paper: background citation

Randomized Clinical Trial to Assess the Efficacy of the System Insulclock® 360 for Insulin Treatment Management in Type 1 Diabetes Patients With Insufficient Glycemic Control

TypeinterventionalSponsorHospital General de SegoviaRan2021 to 2021Enrolled80ConditionsDiabetes Mellitus, Type 1ArmsUse of Insulclock system, both Insulclock device and Insulclock 360 app., Use of Insulclock system, both Insulclock device and Insulclock app on masked mode.
3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update.Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists · 2022
    Guideline
  3. Trial
  4. Trial
  5. Trial
  6. Review
  7. Insulin Injection Behaviors and Association with Glycemic Outcomes in Patients with Diabetes: A Real-World Survey in Spain.Diabetes therapy : research, treatment and education of diabetes and related disorders · 2026
    Article
  8. Observational
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Exploring the Burden of Mealtime Insulin Dosing in Adults and Children With Type 1 Diabetes.Clinical diabetes : a publication of the American Diabetes Association · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Fernando Gomez-PeraltaEndocrinology and Nutrition Unit, Segovia General Hospital, Segovia, Spain.
Cristina AbreuEndocrinology and Nutrition Unit, Segovia General Hospital, Segovia, Spain.
Sara Gomez-RodriguezEndocrinology and Nutrition Unit, Segovia General Hospital, Segovia, Spain.
Margarita Cruz-BravoEndocrinology and Nutrition Unit, Segovia General Hospital, Segovia, Spain.
Cristina María-SanchezEndocrinology and Nutrition Unit, Segovia General Hospital, Segovia, Spain.
Gema PozaEndocrinology and Nutrition Unit, Segovia General Hospital, Segovia, Spain.
Luis Ruiz-ValdepeñasResearch and Development Unit, Insulcloud S.L. (B87131454), Madrid, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Diabetes Mellitus, Type 1Hypoglycemic AgentsInsulinMedication AdherenceMobile ApplicationsBlood GlucoseHumansMalePilot ProjectsBlood GlucoseHypoglycemic AgentsInsulinAdherenceGlucose variabilityInsulclockSelf-managementTreatment satisfaction

Identifiers

PMID32069067
PMCPMC7640744

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.